NCT00348946View on ClinicalTrials.gov

Androgen Effect on Klinefelter Syndrome Motor Outcome

PHASE2CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Klinefelter Syndrome
Interventions
DRUG

androgen oxandrolone

Oxandrolone ,06 \>mg/kg/day, orally, for 2 years

OTHER

placebo

an inactive substance

Trial Locations (1)

19107

Thomas Jefferson University, Department of Pediatrics, 1025 Walnut Street, Suite 726, Philadelphia

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Thomas Jefferson University

OTHER

NCT00348946 - Androgen Effect on Klinefelter Syndrome Motor Outcome | Biotech Hunter | Biotech Hunter